-
A new treatment that kills two genes responsible for causing pancreatic cancer β one of the most fatal forms of the disease β is being hailed as a possible breakthrough.
Dr. James Cleary, an oncologist at the Dana-Farber Cancer Institute in Boston, said pancreatic cancer research had been βleft behindβ β but not anymore.
Sep 21,2018
-
Leading Cancer Researchers Coming Together to Collaborate Stand Up To Cancer (SU2C) hosted its 9th annual Scientific Summit in Santa Monica, CA where all of its funded researchers gather to […]
Feb 05,2019
-
Computational Tools Seek to Identify Pancreatic Cancer Earlier, Provide More Opportunities for Timely, Effective Treatments The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer […]
Mar 30,2019
-
For some cancers, initial treatment with chemotherapy brings positive, but only temporary, results: tumors shrink, but then rebound as the cancer becomes drug-resistant. This pattern of remission-resistance-relapse is particularly true […]
Apr 04,2019
-
Bruce Toma, 69, is making plans for traveling and sprucing up his house. That’s a far cry from the fall of 2017, when he was diagnosed with pancreatic cancer. The […]
May 10,2019
-
She had been dealing with digestive problems for a while, but they were getting worse. It wasnβt until her daughter noticed a pamphlet sitting on a doctorsβ office waiting room […]
Sep 10,2020
-
PROGRAM INFORMATION Each year, more thanΒ 45,000 Americans are lost to pancreatic cancerβparents, grandparents, siblings, children, friends and other beloved members of our communities. And because pancreaticΒ cancerΒ does not discriminate, it also […]
Oct 19,2020
-
By Caitlin Kelly β October 22, 2020 Checking in With Our Dedicated Labs As the COVID pandemic began to hit hard earlier this year, researchers working on pancreatic cancer research […]
Oct 22,2020